Long-term outcomes in dogs with sinonasal aspergillosis treated with intranasal infusions of enilconazole.

Schuller, Simone; Clercx, Cecile (2007). Long-term outcomes in dogs with sinonasal aspergillosis treated with intranasal infusions of enilconazole. Journal of the American Animal Hospital Association, 43(1), pp. 33-38. American Animal Hospital Association 10.5326/0430033

Full text not available from this repository.

Long-term outcomes (mean 38+/-17 months) were evaluated in 27 dogs with sinonasal aspergillosis after successful medical treatment using intranasal infusions of 1% or 2% enilconazole (1%, n=15; 2%, n=12). Long-term outcomes with both treatment protocols were good, with half of the dogs being asymptomatic throughout the follow-up period. The remaining dogs showed mild clinical signs compatible with chronic rhinitis/sinusitis. These clinical signs were interpreted as chronic lymphoplasmacytic rhinitis/sinusitis and episodes of bacterial rather than fungal infection. Three dogs had confirmed reinfection or relapse 2 to 36 months after clinical resolution.

Item Type:	Journal Article (Original Article)
Division/Institute:	05 Veterinary Medicine > Department of Clinical Veterinary Medicine (DKV) > Small Animal Clinic > Small Animal Clinic, Internal Medicine
UniBE Contributor:	Schuller, Simone
Subjects:	600 Technology > 630 Agriculture 600 Technology > 610 Medicine & health
ISSN:	0587-2871
Publisher:	American Animal Hospital Association
Language:	English
Submitter:	Simone Schuller
Date Deposited:	10 Oct 2014 10:34
Last Modified:	05 Dec 2022 14:37
Publisher DOI:	10.5326/0430033
PubMed ID:	17209083
URI:	https://boris.unibe.ch/id/eprint/59116